PHARMAIDS PHARMACEUTICALS LTD.
BSE: 524572
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.00-100.0% | 2.69+222.9% | 0.83-86.0% | 5.97+434.9% | 1.12+741.7% | 0.13-89.0% | 1.21+44.8% | 0.83 |
| Other Income | 0.05-25.5% | 0.06+1.1% | 0.06-68.0% | 0.19-45.1% | 0.35-65.5% | 1.01+25070.0% | 0.00-20.0% | 0.01 |
| Total Income | 0.05-98.3% | 2.75+207.8% | 0.89-85.5% | 6.16+320.9% | 1.46+28.4% | 1.14-6.0% | 1.21+44.5% | 0.84 |
| EXPENSES | ||||||||
| Expenditure | 1.50-66.1% | 4.42-13.8% | 5.13-55.8% | 11.62+62.4% | 7.15+45.4% | 4.92+61.0% | 3.06+50.9% | 2.03 |
| Tax | 0.61+261.6% | -0.38+66.4% | -1.13-65.5% | -0.68+48.7% | -1.33-83.3% | -0.72-387.6% | 0.25+40.0% | 0.18 |
| PROFIT | ||||||||
| PBT | 2.75+262.5% | -1.69+60.1% | -4.24-81.6% | -2.33+59.0% | -5.69-50.5% | -3.78-104.9% | -1.84-55.4% | -1.19 |
| Net Profit | 2.13+262.7% | -1.31+57.8% | -3.11-88.2% | -1.65+62.1% | -4.36-42.7% | -3.06-91.9% | -1.59-58.2% | -1.01 |
| KEY METRICS | ||||||||
| OPM % | — | -40.91%+59.09pp | -100.00%-75.72pp | -24.28%+75.72pp | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | 100.00%+147.70pp | -47.70%+52.30pp | -100.00%-73.16pp | -26.84%+73.16pp | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | 0.61+64.9% | 0.37-58.0% | 0.88+87.2% | 0.47-62.1% | 1.24+44.2% | 0.86+291.1% | -0.45-55.2% | -0.29 |
Corporate Events
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
Notice of 37th Annual General Meeting scheduled to be held o…
BSE Filing ↗Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗Board Meeting
The Board of Directors considered and approved the appointme…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗Board Meeting
Disinvestment/Sale/Disposal of the entire Partnership stake …
BSE Filing ↗Board Meeting
Consideration and approval of the unaudited financial result…
BSE Filing ↗Board Meeting
Considering and approving the Audited Financial Statements (…
BSE Filing ↗Board Meeting
Consider and approve the Unaudited Financial Results for the…
BSE Filing ↗Board Meeting
Consider and approve the unaudited financial results (Standa…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Financial Results (Standalone…
BSE Filing ↗Board Meeting
Consider and approve the Audited Financial Statements (Stand…
BSE Filing ↗